Virtual Medicinal Product (VMP)
-
Amprenavir 150mg capsules
Name Details
|
Current Name
Amprenavir 150mg capsules
|
Start Date
18-09-2003
|
End Date
|
|
Previous Name
Amprenavir 150mg capsules
|
Start Date
29-08-2003
|
End Date
17-09-2003
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- capsule
- Unit Dose UOM
- capsule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral capsule
- Ontology Form/Route
- capsule.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
J05AE05
| BNF |
|
Current BNF
05030100
|
Start Date
04-04-2022
|
End Date
|
|
Previous BNF
05030100
|
Start Date
24-02-2005
|
End Date
03-03-2009
|
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 41783311000001108 |
12-05-2023 |
|
| 134568007 |
29-08-2003 |
11-05-2023 |
VMP Ingredients
VMP ingredients table
| Amprenavir |
Based on Ingredient Substance |
|
150 mg |
|
Name
Amprenavir
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
150
Strength and UOM (Dmr)
Parent Products
-
VTM
Amprenavir
-
VMP
(Current) Amprenavir 150mg capsules
Virtual Medicinal Product Pack (VMPP) Information